Real-time patch-clamp sensing of transport across a barrier tissue Grant US-11885793-B1 United States of America 30 Jan 2024
Effects of space travel on human brain cells Grant US-11697792-B2 United States of America 11 Jul 2023
Compounds and compositions for targeting brain injuries and methods of use thereof Grant US-11458210-B2 United States of America 04 Oct 2022
Compositions and methods for treating nervous system injuries Grant US-11376303-B2 United States of America 05 Jul 2022
Anti-CD100 antibodies and methods for using the same Grant US-11274149-B2 United States of America 15 Mar 2022
Use of semaphorin-4D inhibitory molecules with an immune modulating therapy to inhibit… Grant US-11078295-B2 United States of America 03 Aug 2021
Use of semaphorin-4D binding molecules for treating neurodegenerative disorders Grant US-10800853-B2 United States of America 13 Oct 2020
Use of anti-semaphorin-4D antibodies in combination with an immune modulating therapy to… Grant US-10526414-B2 United States of America 07 Jan 2020
Use of semaphorin-4D binding molecules to promote neurogenesis following stroke Grant US-10494440-B2 United States of America 03 Dec 2019
Use of semaphorin-4D binding molecules for treating neurodegenerative disorders Grant US-10385136-B2 United States of America 20 Aug 2019
Compositions and their use to treat complications of aneurysmal subarachnoid hemorrhage Grant US-10092524-B2 United States of America 09 Oct 2018
USE OF SEMAPHORIN-4D BINDING MOLECULES FOR MODULATION OF BLOOD BRAIN BARRIER PERMEABILITY Grant EP-2766093-B1 European Patent Office 21 Feb 2018
Use of antibodies or antigen-binding fragments thereof that specifically bind semaphorin-4D… Grant US-9828435-B2 United States of America 28 Nov 2017
Anti-CD100 neutralizing antibodies and methods of using the same Grant US-9676840-B2 United States of America 13 Jun 2017
Anti-CD100 antibodies and methods of using the same Grant US-9605055-B2 United States of America 28 Mar 2017
Use of semaphorin-4D binding molecules for treating neurodegenerative disorders Grant US-9598495-B2 United States of America 21 Mar 2017
Use of semaphorin-4D binding molecules for treating neurodegenerative disorders Grant US-9249227-B2 United States of America 02 Feb 2016
Combination of SEMA-4D inhibitors and immunomodulators to inhibit tumors and metastases Grant US-9243068-B2 United States of America 26 Jan 2016
Detection of traumatic brain injury using alpha II spectrin break-down products (SBDP) Grant EP-2348317-B1 European Patent Office 03 Dec 2014